StemCell2MAX
Cantanhede
About StemCell2MAX
StemCell2MAX is a Portuguese biotechnology company with the goal to address the global shortage of high-quality blood/haematopoietic stem cells (HSCs) for both medical and research use. The company has a strong IP position (EU, USA and Japan) on a highly innovative technology that selectively promotes survival and multiplication of highly scarce HSCs (Fonseca-Pereira, et al., Nature 514, 2014). In 2015, StemCell2MAX launched a research use only (RUO) expansion product and achieved a growing sales track record internationally and is currently developing the clinical use of its technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Grant (Jan 2016)
- Website: stemcell2max.weebly.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Hospital
Social Profiles
Canonical: https://fsome.com/organization/stemcell2max-3287678 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.